Speclipse
Latest round
- Series B
Last raised
- Aug 2021
Total raised
- $11M
Investors
- 9
About Speclipse
Based in South Korea, Speclipse, Inc.Speclipse, Inc. was founded in 2015 in Gyeonggi-do, South Korea, focusing on innovative cancer diagnostics. The company is co-founded by Sung Pyun and Wanki Min, with Sung Pyun currently serving as CEO.Speclipse, Inc. specializes in advanced cancer diagnostic solutions utilizing Laser-Induced Plasma Spectroscopy (LIPS) and Artificial Intelligence (AI) technology. Their flagship product, Spectra-Scope®, is a portable device that analyzes the biochemical properties of skin tissue to provide rapid oncological diagnostics. It employs a deep-learning AI-based diagnostic algorithm, enabling dermatologists to efficiently identify and treat various skin lesions.Speclipse, Inc. generates revenue through direct sales of its medical devices, particularly the Spectra-Scope®, along with its advanced laser treatments. Transactions are made through direct-to-consumer sales to dermatologists and medical facilities, where clients purchase devices and associated services. The company may also engage in partnerships with healthcare providers and clinics to broaden access to their technologies. Pricing structures vary, reflecting the specialized nature of their products, which may involve one-time purchases or service agreements for ongoing support.Speclipse, Inc. The company is focused on the design and development of new products, specifically aiming to introduce additional diagnostic tools by mid-2023. Plans for expansion include entering new markets in Southeast Asia and Europe by late 2023, aiming to increase accessibility to their advanced diagnostic solutions.
Who invested in Speclipse
9 investors across 3 rounds
See all investors in Speclipse
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Speclipse
Who invested in Speclipse?
Speclipse has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Speclipse raised?
Speclipse has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Speclipse last raise money?
Speclipse's most recent round on record is a Series B, in Aug 2021.
What does Speclipse do?
Based in South Korea, Speclipse, Inc.
Where is Speclipse headquartered?
Speclipse is headquartered in Gyeonggi-do, South Korea.
Which VCs invest in companies like Speclipse?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Speclipse's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Speclipse? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.